Evolent Health, Inc. - Class A Shares (EVH)

$26.34

+0.19

(+0.73%)▲

Market is closed - opens 7 PM, 07 Oct 2024

Performance

  • $26.31
    $27.27
    $26.34
    downward going graph

    0.11%

    Downside

    Day's Volatility :3.52%

    Upside

    3.41%

    downward going graph
  • $17.98
    $35.00
    $26.34
    downward going graph

    31.74%

    Downside

    52 Weeks Volatility :48.63%

    Upside

    24.74%

    downward going graph

Returns

PeriodEvolent Health, Inc. - Class A SharesSector (Health Care)Index (Russel 2000)
3 Months
30.75%
4.9%
0.0%
6 Months
-13.87%
5.8%
0.0%
1 Year
-1.73%
17.8%
0.0%
3 Years
-18.91%
20.1%
-20.6%

Highlights

Market Capitalization
3.1B
Book Value
$9.19
Earnings Per Share (EPS)
-0.94
PEG Ratio
-1.37
Wall Street Target Price
42.16
Profit Margin
-3.16%
Operating Margin TTM
1.46%
Return On Assets TTM
1.0%
Return On Equity TTM
-5.94%
Revenue TTM
2.4B
Revenue Per Share TTM
20.71
Quarterly Revenue Growth YOY
37.9%
Gross Profit TTM
316.6M
EBITDA
136.3M
Diluted Eps TTM
-0.94
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
1.35
EPS Estimate Next Year
1.72
EPS Estimate Current Quarter
0.25
EPS Estimate Next Quarter
0.35

Analyst Recommendation

Buy
    89%Buy
    10%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Evolent Health, Inc. - Class A Shares(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
16
15
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 60.06%

Current $26.34
Target $42.16

Company Financials

FY18Y/Y Change
Revenue
627.1M
↑ 44.17%
Net Income
-52.7M
↓ 13.2%
Net Profit Margin
-8.4%
↑ 5.55%
FY19Y/Y Change
Revenue
846.4M
↑ 34.98%
Net Income
-305.6M
↑ 480.31%
Net Profit Margin
-36.1%
↓ 27.7%
FY20Y/Y Change
Revenue
1.0B
↑ 20.8%
Net Income
-334.2M
↑ 9.38%
Net Profit Margin
-32.69%
↑ 3.41%
FY21Y/Y Change
Revenue
908.0M
↓ 11.2%
Net Income
-30.3M
↓ 90.94%
Net Profit Margin
-3.34%
↑ 29.35%
FY22Y/Y Change
Revenue
1.4B
↑ 48.91%
Net Income
-18.7M
↓ 38.25%
Net Profit Margin
-1.38%
↑ 1.96%
FY23Y/Y Change
Revenue
2.0B
↑ 45.26%
Net Income
-113.0M
↑ 504.46%
Net Profit Margin
-5.76%
↓ 4.38%
Q1 FY23Q/Q Change
Revenue
427.7M
↑ 11.83%
Net Income
-20.0M
↑ 76.07%
Net Profit Margin
-4.67%
↓ 1.7%
Q2 FY23Q/Q Change
Revenue
469.1M
↑ 9.69%
Net Income
-34.3M
↑ 71.77%
Net Profit Margin
-7.32%
↓ 2.65%
Q3 FY23Q/Q Change
Revenue
511.0M
↑ 8.93%
Net Income
-25.3M
↓ 26.22%
Net Profit Margin
-4.96%
↑ 2.36%
Q4 FY23Q/Q Change
Revenue
556.1M
↑ 8.81%
Net Income
-33.4M
↑ 31.93%
Net Profit Margin
-6.01%
↓ 1.05%
Q1 FY24Q/Q Change
Revenue
639.7M
↑ 15.03%
Net Income
-17.3M
↓ 48.28%
Net Profit Margin
-2.7%
↑ 3.31%
Q2 FY24Q/Q Change
Revenue
647.1M
↑ 1.17%
Net Income
1.6M
↓ 109.24%
Net Profit Margin
0.25%
↑ 2.95%
FY18Y/Y Change
Total Assets
1.7B
↑ 31.2%
Total Liabilities
532.9M
↑ 100.05%
FY19Y/Y Change
Total Assets
1.5B
↓ 13.02%
Total Liabilities
569.0M
↑ 6.76%
FY20Y/Y Change
Total Assets
1.4B
↓ 8.53%
Total Liabilities
750.6M
↑ 31.92%
FY21Y/Y Change
Total Assets
1.4B
↑ 3.6%
Total Liabilities
725.8M
↓ 3.3%
FY22Y/Y Change
Total Assets
1.8B
↑ 28.03%
Total Liabilities
957.9M
↑ 31.97%
FY23Y/Y Change
Total Assets
2.7B
↑ 47.49%
Total Liabilities
1.6B
↑ 68.35%
Q1 FY23Q/Q Change
Total Assets
2.6B
↑ 42.49%
Total Liabilities
1.5B
↑ 53.23%
Q2 FY23Q/Q Change
Total Assets
2.6B
↑ 2.22%
Total Liabilities
1.6B
↑ 5.85%
Q3 FY23Q/Q Change
Total Assets
2.7B
↑ 0.86%
Total Liabilities
1.6B
↑ 1.28%
Q4 FY23Q/Q Change
Total Assets
2.7B
↑ 0.4%
Total Liabilities
1.6B
↑ 2.48%
Q1 FY24Q/Q Change
Total Assets
2.6B
↓ 1.37%
Total Liabilities
1.6B
↓ 1.05%
Q2 FY24Q/Q Change
Total Assets
2.5B
↓ 6.38%
Total Liabilities
1.4B
↓ 10.93%
FY18Y/Y Change
Operating Cash Flow
-20.7M
↓ 26.14%
Investing Cash Flow
-160.4M
↑ 1207.58%
Financing Cash Flow
274.0M
↑ 65.52%
FY19Y/Y Change
Operating Cash Flow
-42.6M
↑ 106.5%
Investing Cash Flow
-181.6M
↑ 13.26%
Financing Cash Flow
-35.5M
↓ 112.97%
FY20Y/Y Change
Operating Cash Flow
-16.2M
↓ 61.95%
Investing Cash Flow
261.1M
↓ 243.74%
Financing Cash Flow
-11.9M
↓ 66.63%
FY21Y/Y Change
Operating Cash Flow
38.7M
↓ 338.81%
Investing Cash Flow
-15.8M
↓ 106.05%
Financing Cash Flow
-29.5M
↑ 149.1%
FY22Y/Y Change
Operating Cash Flow
-11.6M
↓ 129.82%
Investing Cash Flow
-259.1M
↑ 1541.42%
Financing Cash Flow
131.5M
↓ 545.18%
Q1 FY23Q/Q Change
Operating Cash Flow
-8.0M
↓ 122.34%
Investing Cash Flow
-395.0M
↑ 8764.3%
Financing Cash Flow
379.7M
↓ 3598.52%
Q2 FY23Q/Q Change
Operating Cash Flow
654.0K
↓ 108.2%
Investing Cash Flow
-8.4M
↓ 97.89%
Financing Cash Flow
23.3M
↓ 93.86%
Q3 FY23Q/Q Change
Operating Cash Flow
60.5M
↑ 9153.98%
Investing Cash Flow
-409.5M
↑ 4801.75%
Financing Cash Flow
-37.4M
↓ 260.17%

Technicals Summary

Sell

Neutral

Buy

Evolent Health, Inc. - Class A Shares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
-13.84%
-13.87%
-1.73%
-18.91%
241.38%
Solventum Corp
Solventum Corp
2.53%
-4.0%
-2.66%
-2.66%
-2.66%
Doximity, Inc.
Doximity, Inc.
21.48%
68.04%
102.95%
-44.5%
-18.17%
Veeva Systems Inc.
Veeva Systems Inc.
-5.01%
-4.75%
1.55%
-26.95%
34.01%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
2.97%
1.59%
32.96%
48.59%
48.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
712.02
NA
-1.37
1.35
-0.06
0.01
NA
9.19
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
54.36
54.36
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
54.69
54.69
1.18
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
26.31
26.31
2.39
4.25
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
Buy
$3.1B
241.38%
712.02
-3.16%
Solventum Corp
Solventum Corp
Hold
$10.8B
-2.66%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$8.1B
-18.17%
54.36
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$33.6B
34.01%
54.69
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$41.6B
48.59%
26.31
8.1%

Insights on Evolent Health, Inc. - Class A Shares

  • Increasing Revenue

    Revenue is up for the last 14 quarters, 215.07M → 647.14M (in $), with an average increase of 8.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -33.41M → 1.59M (in $), with an average increase of 638.0% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 102.9% return, outperforming this stock by 104.6%

Institutional Holdings

  • Wellington Management Company LLP

    9.60%

  • Vanguard Group Inc

    9.51%

  • BlackRock Inc

    7.47%

  • RA Capital Management, LLC

    7.32%

  • FMR Inc

    5.27%

  • William Blair Investment Management, LLC

    4.32%

Company Information

our company evolent health supports progressive health care systems lead, build and own the path to value-based care. headquartered in arlington, virginia, we are backed by: the advisory board company (nasdaq: abco), university of pittsburgh medical center health plan, and tpg growth. we integrate the people, processes and technology needed to advance value-based care delivery and innovative payment models. our culture we’ve built a team of dedicated individuals who genuinely enjoy working together. our accessible leadership team cultivates an open-door environment. we take smart risks and when we fail, we fail forward. we respect and encourage commitments outside of work. while we don’t all work the same way or the same hours, we are all dedicated to exceptional results. our benefits treadmill desks, healthy snacks and wellness challenges are just part of our resolve to promote a healthy (and fun!) work environment. we recognize and reward our most valuable asset—our team—wi

Organization
Evolent Health, Inc. - Class A Shares
Employees
4700
CEO
Mr. Seth Barrie Blackley
Industry
Miscellaneous Commercial Services

Discover More

FAQs